200Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
Sweden
Neuroscience Intelligence
Sweden neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #15 of 50 · Data maturity A · Research score 41.6 · Data confidence 100.0 / 100 · Snapshot 2026-10-29 06:18 UTC.
43Recruiting trials
291Publications
78Institutions
Executive interpretation
Sweden ranks #15 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. Clinical metrics and NCT evidence use only records classified as in_scope or related; out_of_scope records remain preserved outside these analytical counts. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Karolinska Institutet489 recruiting
Merck Sharp & Dohme LLC86 recruiting
Hoffmann-La Roche80 recruiting
Region Skane63 recruiting
Boehringer Ingelheim60 recruiting
Eli Lilly and Company50 recruiting
Pfizer50 recruiting
Göteborg University50 recruiting
Sahlgrenska University Hospital51 recruiting
Uppsala University51 recruiting
Disease activity
Alzheimers44trials
Parkinsons22trials
Adhd15trials
Stroke14trials
Depression12trials
Other Neurology10trials
Epilepsy10trials
Other Psychiatry9trials
Multiple Sclerosis8trials
Anxiety8trials
Research institutions
Kristianstad UniversityOpenAlexlinked institution
Institute for Futures StudiesOpenAlexlinked institution
University of SkövdeOpenAlexlinked institution
Chalmers University of TechnologyOpenAlexlinked institution
Swedish Collegium for Advanced StudyOpenAlexlinked institution
Linnaeus UniversityOpenAlexlinked institution
Bolin Centre for Climate ResearchOpenAlexlinked institution
Linköping University HospitalOpenAlexlinked institution
Swedish Institute for Health SciencesOpenAlexlinked institution
Sachs' Children and Youth HospitalOpenAlexlinked institution
Clinical evidence trail
NCT07216703A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)RECRUITING
NCT07201090Effects and Implementation of a Brief Version of Parent-Child Interaction TherapyNOT_YET_RECRUITING
NCT07169747Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia NervosaRECRUITING
NCT06966700A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)RECRUITING
NCT06952504A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)RECRUITING
NCT06937892Transdiagnostic Metacognitive Therapy Compared to Disorder-Specific Cognitive-Behavioral Therapy for Anxiety DisordersRECRUITING
Research evidence trail
PUBMEDDepression and risk of future suicidal behaviour in patients with deliberate self-harm.2027-01-01
PUBMEDFrom safety to agency: experiences of self-admission among patients with diverse mental health needs.2026-12-31
PUBMEDAnalytical evaluation and method comparison of an orexin-A radioimmunoassay in cerebrospinal fluid: establishing a cut-off value for type 1 narcolepsy and exploring genetic and clinical characteristics.2026-12-01
PUBMEDCandidate biomarkers in narcolepsy in H1N1-vaccinated cohorts: A proteomic and transcriptomic study.2026-12-01
PUBMEDCaring for young minds: general practitioners' self-assessed competence in child and adolescent psychiatry.2026-12-01
PUBMEDDifferential contributions of PTSD symptom clusters and their associations with resilience in traumatized individuals with a refugee background.2026-12-01
PUBMEDConvictions among adolescents and young adults in Swedish substance use treatment: A latent class analysis.2026-12-01
PUBMEDA desire to be embraced - the lived experience of encountering primary health care for a person with mental health problems. A descriptive phenomenological study.2026-12-01
PUBMEDDoing the groundwork at home, working through it together: patient experiences of blended cognitive therapy for PTSD in routine care.2026-12-01
PUBMEDParental support moderates the interaction of COMT and BDNF genotypes with early life adversity on problem gambling severity index scores among young adults.2026-12-01
PUBMEDPsychometric properties of the Swedish version of the PTSD checklist for DSM-5 (PCL-5) in a mixed trauma sample - examining internal consistency, convergent validity, latent structure, and screening performance.2026-12-01
World Bank context
Macro indicators are shown only where a timestamped World Bank source row exists. Latest collection in this report: 2026-10-24 04:18 UTC. They are context, not NeuroRisk predictions.
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.